A bisphosphonate with a low hydroxyapatite binding affinity prevents bone loss in mice after ovariectomy and reverses rapidly with treatment cessation

AA Coffman, J Basta Pljakic, RM Guerra… - Journal of Bone and …, 2021 - academic.oup.com
Bisphosphonates (BPs) are a mainstay of osteoporosis treatment; however, concerns about
bone health based on oversuppression of remodeling remain. Long term bone remodeling …

A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation

AA Coffman, J Basta-Pljakic, RM Guerra, FH Ebetino… - 2021 - academicworks.cuny.edu
Bisphosphonates (BPs) are a mainstay of osteoporosis treatment; however, concerns about
bone health based on oversuppression of remodeling remain. Long-term bone remodeling …

A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation.

AA Coffman, J Basta-Pljakic, RM Guerra, FH Ebetino… - JBMR Plus, 2021 - europepmc.org
Bisphosphonates (BPs) are a mainstay of osteoporosis treatment; however, concerns about
bone health based on oversuppression of remodeling remain. Long‐term bone remodeling …

A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation

AA Coffman, J Basta‐Pljakic, RM Guerra… - JBMR Plus, 2021 - Wiley Online Library
Bisphosphonates (BPs) are a mainstay of osteoporosis treatment; however, concerns about
bone health based on oversuppression of remodeling remain. Long‐term bone remodeling …

A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation

AA Coffman, J Basta‐Pljakic, RM Guerra… - JBMR Plus, 2021 - Wiley Online Library
Bisphosphonates (BPs) are a mainstay of osteoporosis treatment; however, concerns about
bone health based on oversuppression of remodeling remain. Long‐term bone remodeling …

A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation

AA Coffman, J Basta-Pljakic, RM Guerra, FH Ebetino… - 2021 - scholarworks.iupui.edu
Bisphosphonates (BPs) are a mainstay of osteoporosis treatment; however, concerns about
bone health based on oversuppression of remodeling remain. Long‐term bone remodeling …

A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation

AA Coffman, J Basta-Pljakic, RM Guerra… - JBMR …, 2021 - pubmed.ncbi.nlm.nih.gov
Bisphosphonates (BPs) are a mainstay of osteoporosis treatment; however, concerns about
bone health based on oversuppression of remodeling remain. Long-term bone remodeling …

[HTML][HTML] A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation

AA Coffman, J Basta‐Pljakic, RM Guerra, FH Ebetino… - JBMR Plus, 2021 - ncbi.nlm.nih.gov
Bisphosphonates (BPs) are a mainstay of osteoporosis treatment; however, concerns about
bone health based on oversuppression of remodeling remain. Long‐term bone remodeling …

A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation

AA Coffman, J Basta-Pljakic, RM Guerra, FH Ebetino… - 2021 - academic.oup.com
Bisphosphonates (BPs) are a mainstay of osteoporosis treatment; however, concerns about
bone health based on oversuppression of remodeling remain. Long-term bone remodeling …

A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation

AA Coffman, J Basta‐Pljakic, RM Guerra… - JBMR …, 2021 - search.proquest.com
Bisphosphonates (BPs) are a mainstay of osteoporosis treatment; however, concerns about
bone health based on oversuppression of remodeling remain. Long‐term bone remodeling …